Euro-Med Laboratories Phil., Inc. is a Philippines-based company, which is engaged in the manufacture of pharmaceutical products, such as large and small volume parenterals and other solutions. The Company also manufactures sterile water for injection and other solutions, such as ophthalmic, inhalation, irrigation and dialysis. Its segments are the manufacturing segment, which manufactures pharmaceutical products; the service segment, which operates dialysis centers, and the food service segment, which operates quick service restaurant (QSR), catering, food production and other related services. The Company manufactures parental solutions in glass packaging. The Company's products include Lifeshield Macrodip Non-DEHP, Lifeshield Macrodip with Clave, Lifeshield Blood Set Non-DEHP, Lifeshield Macrodip w/ Clave, Lifeshield Soluset Burette Non-DEHP and Lifeshield Twin Site Non-DEHP. The Company's subsidiaries include Hemotek Renal Center, Inc. and CafeFrance Corp.
Ford US Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.